4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
ABIVAX Société Anonyme (ABVX) operates in the Biotechnology industry and is headquartered in Paris, France with about 80 employees. Its market capitalization is roughly €9 billion. In the fiscal year ended 2025-12-31, ABVX reported €0M in revenue and (€336M) in net income.
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €0M | €0M | €0M | €0M | — |
| Gross Profit | — | — | — | (€51M) | (€46M) |
| Operating Income (EBIT) | (€246M) | (€173M) | (€127M) | (€51M) | — |
| Net Income | (€336M) | (€176M) | (€148M) | (€61M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | €0M | €0M | €0M | €0M | €0M |
| Operating Income (EBIT) | (€56M) | (€72M) | (€81M) | (€46M) | (€47M) |
| Net Income | (€48M) | (€82M) | (€153M) | (€48M) | (€52M) |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | €0M | €0M | €0M | €0M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | €0M | €0M | €0M | €0M | €0M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €584M | €205M | €327M | €76M | — |
| Total Liabilities | €129M | €165M | €131M | €68M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ABVX viewer.
About TickerBase · Data methodology & sources · Privacy · Terms